Key data
|
|
2020 |
|
2019 |
||||||||||||
|
|
|
|
|
||||||||||||
People |
|
|
|
|
||||||||||||
Workforce at 31 December (headcount) |
|
23,127 |
|
22,174 |
||||||||||||
Female:male ratio2 |
|
29:71 |
|
28:72 |
||||||||||||
Total employee benefit costs (in € million) |
|
1,848 |
|
1,811 |
||||||||||||
Frequency Index of Recordable Injuries (per 100 DSM employees and contractor employees) |
|
0.24 |
|
0.28 |
||||||||||||
Employee Engagement Index (in %) |
|
76 |
|
74 |
||||||||||||
|
|
|
|
|
||||||||||||
Planet |
|
|
|
|
||||||||||||
Primary energy use (in PJ) |
|
21.5 |
|
21.2 |
||||||||||||
Energy Efficiency Improvement (in %, year-on-year) |
|
5.7 |
|
2.3 |
||||||||||||
Greenhouse gas emissions, market-based |
|
1.2 |
|
1.2 |
||||||||||||
Greenhouse gas scope 1 + 2 cumulative absolute reduction |
|
25 |
|
25 |
||||||||||||
Water consumption (x million m3) |
|
24 |
|
23 |
||||||||||||
|
|
|
|
|
||||||||||||
Brighter Living Solutions (as % of running business) |
|
63 |
|
63 |
||||||||||||
|
|
|
|
|
||||||||||||
Profit (in € million) |
|
|
|
|
||||||||||||
Net sales from continuing operations |
|
8,106 |
|
7,998 |
||||||||||||
Adjusted EBITDA from continuing operations3 |
|
1,534 |
|
1,551 |
||||||||||||
EBITDA from continuing operations |
|
1,368 |
|
1,457 |
||||||||||||
Adjusted operating profit from continuing operations (EBIT)3 |
|
929 |
|
989 |
||||||||||||
Operating profit from continuing operations (EBIT) |
|
662 |
|
872 |
||||||||||||
Net profit for the year |
|
508 |
|
764 |
||||||||||||
Adjusted net operating free cash flow3 |
|
955 |
|
801 |
||||||||||||
Capital expenditure, cash based |
|
585 |
|
609 |
||||||||||||
Dividend for DSM shareholders (based on profit appropriation) |
|
4.204 |
|
425 |
||||||||||||
Net debt |
|
2,577 |
|
1,144 |
||||||||||||
Shareholders’ equity |
|
7,399 |
|
7,731 |
||||||||||||
Total assets |
|
14,364 |
|
13,443 |
||||||||||||
Capital employed |
|
10,560 |
|
9,311 |
||||||||||||
Market capitalization at 31 December5 |
|
25,545 |
|
21,063 |
||||||||||||
|
|
|
|
|
||||||||||||
Per ordinary share in € |
|
|
|
|
||||||||||||
Net earnings |
|
2.91 |
|
4.27 |
||||||||||||
Dividend |
|
2.404 |
|
2.40 |
||||||||||||
|
|
|
|
|
||||||||||||
Financial ratios (%) |
|
|
|
|
||||||||||||
Sales to high-growth economies / net sales (continuing operations) |
|
44 |
|
45 |
||||||||||||
Innovation sales / net sales (continuing operations) |
|
20 |
|
21 |
||||||||||||
Adjusted EBITDA margin (continuing operations)3 |
|
18.9 |
|
19.4 |
||||||||||||
Average working capital / annualized net sales (continuing operations) |
|
22.3 |
|
21.2 |
||||||||||||
ROCE (continuing operations)3 |
|
10.4 |
|
12.3 |
||||||||||||
Gearing (net debt / equity plus net debt) |
|
25.6 |
|
12.7 |
||||||||||||
Equity / total assets |
|
52.1 |
|
58.3 |
||||||||||||
Cash provided by operating activities / Adjusted EBITDA3 |
|
90.5 |
|
82,2 |
||||||||||||
|